Table 2.
Metabolite | DBS | Plasma | ||||
---|---|---|---|---|---|---|
Mean difference | 95% CI | q‐Value | Mean difference | 95% CI | q‐Value | |
Arginine | −1.53 | −2 to −1.07 | 0.0001 | −1.31 | −1.66 to −0.955 | <0.0001 |
Asparagine | −0.803 | −1.19 to −0.419 | 0.0043 | 0.258 | −0.307–0.824 | 0.5788 |
C16:1 hexadecenoylcarnitine | 0.135 | −0.543–0.814 | 0.8118 | −0.961 | −1.5 to −0.427 | 0.0150 |
C6: hexanoylcarnitine | −0.917 | −1.57 to −0.268 | 0.0448 | 0.105 | −0.501–0.711 | 0.8891 |
C8:1 octenoylcarnitine | −0.389 | −0.932–0.154 | 0.3465 | −0.916 | −1.51 to −0.325 | 0.0410 |
Carnitine free | −0.703 | −1.47–0.0627 | 0.1876 | 1.05 | 0.573–1.53 | 0.0029 |
Citrulline | −1.37 | −1.81 to −0.932 | 0.0001 | −1.12 | −1.57 to −0.663 | 0.0011 |
Glutamine | −0.91 | −1.55 to −0.273 | 0.0448 | −0.287 | −0.987–0.413 | 0.6060 |
Histidine | −1.84 | −2.25 to −1.44 | >0.0001 | −1.45 | −1.84 to −1.05 | >0.0001 |
Leucine/isoleucine | −0.676 | −1.13 to −0.221 | 0.0420 | −0.414 | −1–0.173 | 0.4740 |
Methylhistidine | −1.09 | −1.6 to −0.574 | 0.0043 | −0.697 | −1.3 to −0.0985 | 0.1664 |
Methionine | 0.889 | 0.274–1.5 | 0.0448 | 0.365 | −0.286–1.02 | 0.4907 |
Ornithine | −1.61 | −1.99 to −1.22 | >0.0001 | 1.14 | 0.694–1.59 | 0.0009 |
Q14: arginine/ornithine | −0.41 | −1.04–0.218 | 0.3997 | −1.36 | −1.71 to −1.01 | >0.0001 |
Q18: triglylcarnitine/leucine/isoleucine | 0.725 | 0.293–1.16 | 0.0214 | 0.315 | −0.265–0.895 | 0.4907 |
Serine | −1.24 | −1.79 – −0.677 | 0.0036 | −0.283 | −0.862–0.297 | 0.5517 |
Threonine | −1.07 | −1.67 – −0.472 | 0.0149 | −0.579 | −1.25–0.0892 | 0.3885 |
Negative values correspond to an overall lower mean in the patient group compared with the control group, and positive values to a higher mean. Only significant differences in either DBS or PS (with a q‐value ≤ 0.05 following correlation for multiple comparisons) are reported. The remaining set of data is given in Table S3 .
95% CI, 95% confidence interval; DBS, dried blood sample.